Restenosis assessed by quantitative angiography. Lessons learned from two european multicenter trials

Benno J. Rensing; Walter Hermans; Patrick W. Serruys

doi:10.1007/978-94-015-8358-9_28

Restenosis assessed by quantitative angiography. Lessons learned from two european multicenter trials

In: Restenosis assessed by quantitative angiography. Lessons learned from two european multicenter trials (Developments in cardiovascular medicine)

Chapter In A Book 1994 English

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Chapter in a book2020

Lessons Learned From a Failed Experiment

Paul Slovic

Article2024

Two decades of advances in clinical oncology — lessons learned and future directions

Susana Banerjee, Christopher M. Booth, Éduardo Bruera, Markus W. Büchler, Alexander Drilon, Terry J. Fry, Irene M. Ghobrial, Luca Gianni, Rakesh K. Jain, Guido Guido Kroemer, Josep M. Llovet, Georgina V. Long, Klaus Pantel, Kathy Pritchard‐Jones, Howard I. Scher, Josep Tabernero, Ralph R. Weichselbaum, Michael Weller, Yi‐Long Wu

Nature Reviews Clinical Oncology

Editorial Material2004

Editorial: Data Mining Lessons Learned

Nada Lavrač, Hiroshi Motoda, Tom Fawcette

Machine Learning

Chapter in a book1993

Experiences of a quantitative coronary angiographic core laboratory in restenosis prevention trials

Walter Hermans, Benno J. Rensing, Jaap Pameyer, Patrick W. Serruys

Chapter in a book1994

Experiences of a quantitative coronary angiographic core laboratory in restenosis prevention trials

Victor A. Umans, Walter Hermans, Jean‐Paul R. Herrman, Jaap Pameyer, Patrick W. Serruys

Restenosis assessed by quantitative angiography. Lessons learned from two european multicenter trials

Abstract

Discussion(0)

Related publications

Lessons Learned From a Failed Experiment

Two decades of advances in clinical oncology — lessons learned and future directions

Editorial: Data Mining Lessons Learned

Experiences of a quantitative coronary angiographic core laboratory in restenosis prevention trials

Experiences of a quantitative coronary angiographic core laboratory in restenosis prevention trials